Tissue engineering of oral mucosa has emerged as a promising alternative for reconstructing oral lesions. This systematic review and meta-analysis evaluated advancements in the biofabrication of artificial oral mucosa, focusing on its components, methods, and outcomes. A total of 57 studies were included, primarily preclinical in vitro research. The predominant cell sources were primary oral keratinocytes and fibroblasts, with collagen being the most utilized biomaterial. The immersion and air technique was the main biofabrication method. The meta-analysis revealed an average epithelial thickness of 73.18 μm and a maturation score of 5.13/6. In vivo studies indicated a trend toward greater epithelial stratification compared with in vitro studies. The presence of cellularized stroma, decellularized scaffolds, and custom growth factors correlated with increased epithelial thickness although without statistically significant differences. This study provides a comprehensive overview of the current state of tissue-engineered oral mucosa, highlighting its clinical potential.
Impact Statement
This systematic review and meta-analysis provides the most comprehensive synthesis to date of biofabrication strategies for tissue-engineered oral mucosa (TEOM). By critically evaluating 57 studies, it evaluates key design variables—such as biomaterials, cell sources, and culture techniques—and their influence on epithelial thickness and maturation. The findings highlight the translational relevance of TEOM for future clinical applications.
Ibanez-CortesM, Martin-PiedraMA, Blanco-ElicesC, et al.Histological characterization of the human masticatory oral mucosa. A histochemical and immunohistochemical study. Microsc Res Tech, 2023; 86(12):1712–1724; doi: 10.1002/jemt.24398
2.
IzumiK, YortchanW, AizawaY, et al.Recent trends and perspectives in reconstruction and regeneration of intra/extra-oral wounds using tissue-engineered oral mucosa equivalents. Jpn Dent Sci Rev, 2023; 59:365–374; doi: 10.1016/j.jdsr.2023.10.002
3.
KamalakkannanS, RajanF, ShanmugamJ, et al.Margin status, adjuvant treatment and recurrence in buccal cancer. Oral Oncol, 2024; 156:106927; doi: 10.1016/j.oraloncology.2024.106927
4.
ConsortiG, MonarchiG, PaglianitiM, et al.Reconstruction of oral mucosal defects with regenerative dermal matrix after T1-T2 squamocellular carcinoma resection. J Stomatol Oral Maxillofac Surg, 2024; 125(4S):101911; doi: 10.1016/j.jormas.2024.101911
5.
Fernandez-Valades-GamezR, GarzonI, Liceras-LicerasE, et al.Usefulness of a bioengineered oral mucosa model for preventing palate bone alterations in rabbits with a mucoperiostial defect. Biomed Mater, 2016; 11(1):15015; doi: 10.1088/1748-6041/11/1/015015
6.
Sanchez-QuevedoMC, AlaminosM, CapitanLM, et al.Histological and histochemical evaluation of human oral mucosa constructs developed by tissue engineering. Histol Histopathol, 2007; 22(6):631–640.
Santisteban-EspejoA, Martin-PiedraMA, CamposA, et al.Information and scientific impact of advanced therapies in the age of mass media: Altmetrics-based analysis of tissue engineering. J Med Internet Res, 2021; 23(11):e25394; doi: 10.2196/25394
9.
IzumiK, KatoH, FeinbergSE. Chapter 53 - Tissue Engineered Oral Mucosa. In: Stem Cell Biology and Tissue Engineering in Dental Sciences. (VishwakarmaA, SharpeP, ShiS, et al. eds.) Academic Press: Boston; 2015; pp. 721–731.
10.
VacantiJP, VacantiCA. Chapter 1 - The History and Scope of Tissue Engineering. In: Principles of Tissue Engineering (Fourth Edition). (LanzaR, LangerR, VacantiJ. eds.) Academic Press: Boston; 2014; pp. 3–8.
11.
ChepelovaN, SagitovaG, MunblitD, et al.The search for an optimal tissue-engineered urethra model for clinical application based on preclinical trials in male animals: A systematic review and meta-analysis. Bioeng Transl Med, 2024; 9(6):e10700; doi: 10.1002/btm2.10700
12.
van den BoschAS, VerwilligenRAF, PijpeA, et al.; National Burn Care, Education & Research group, The Netherlands. Outcomes of dermal substitutes in burns and burn scar reconstruction: A systematic review and meta-analysis. Wound Repair Regen, 2024; 32(6):960–978; doi: 10.1111/wrr.13226
13.
IzumiK, TerashiH, MarceloCL, et al.Development and characterization of a tissue-engineered human oral mucosa equivalent produced in a serum-free culture system. J Dent Res, 2000; 79(3):798–805; doi: 10.1177/00220345000790030301
14.
BauerHK, FleschD, WalentaS, et al.Primary mucosal epithelial cell cultivation: A reliable and accelerated isolation. Tissue Eng Part C Methods, 2019; 25(2):82–92; doi: 10.1089/ten.TEC.2018.0327
15.
OllingtonB, ColleyHE, MurdochC. Immunoresponsive tissue-engineered oral mucosal equivalents containing macrophages. Tissue Eng Part C Methods, 2021; 27(8):462–471; doi: 10.1089/ten.TEC.2021.0124
16.
AlmelaT, BrookIM, MoharamzadehK. Development of three-dimensional tissue engineered bone-oral mucosal composite models. J Mater Sci Mater Med, 2016; 27(4):65; doi: 10.1007/s10856-016-5676-7
17.
KinikogluB, Rodriguez-CabelloJC, DamourO, et al.The influence of elastin-like recombinant polymer on the self-renewing potential of a 3D tissue equivalent derived from human lamina propria fibroblasts and oral epithelial cells. Biomaterials, 2011; 32(25):5756–5764; doi: 10.1016/j.biomaterials.2011.04.054
18.
LiuJ, LammeEN, Steegers-TheunissenRP, et al.Cleft palate cells can regenerate a palatal mucosa in vitro. J Dent Res, 2008; 87(8):788–792; doi: 10.1177/154405910808700806
19.
SuzukiA, KodamaY, MiwaK, et al.Manufacturing micropatterned collagen scaffolds with chemical-crosslinking for development of biomimetic tissue-engineered oral mucosa. Sci Rep, 2020; 10(1):22192; doi: 10.1038/s41598-020-79114-3
20.
ChenLC, KuoS, LloydWR, et al.Optical metric assessed engineered tissues over a range of viability states. Tissue Eng Part C Methods, 2019; 25(5):305–313; doi: 10.1089/ten.TEC.2018.0344
21.
UenoyamaA, KakizakiI, ShiomiA, et al.Effects of C-xylopyranoside derivative on epithelial regeneration in an in vitro 3D oral mucosa model. Biosci Biotechnol Biochem, 2016; 80(7):1344–1355; doi: 10.1080/09168451.2016.1153957
22.
SuebsamarnO, KamimuraY, SuzukiA, et al.In-process monitoring of a tissue-engineered oral mucosa fabricated on a micropatterned collagen scaffold: Use of optical coherence tomography for quality control. Heliyon, 2022; 8(11):e11468; doi: 10.1016/j.heliyon.2022.e11468
23.
SuzukiA, KatoH, KawakamiT, et al.Development of microstructured fish scale collagen scaffolds to manufacture a tissue-engineered oral mucosa equivalent. J Biomater Sci Polym Ed, 2020; 31(5):578–600; doi: 10.1080/09205063.2019.1706147
24.
ChenLC, LloydWR, KuoS, et al.The potential of label-free nonlinear optical molecular microscopy to non-invasively characterize the viability of engineered human tissue constructs. Biomaterials, 2014; 35(25):6667–6676; doi: 10.1016/j.biomaterials.2014.04.080
25.
SlimK, NiniE, ForestierD, et al.Methodological index for non-randomized studies (minors): Development and validation of a new instrument. ANZ J Surg, 2003; 73(9):712–716; doi: 10.1046/j.1445-2197.2003.02748.x
26.
Gonzalez-QuevedoD, Martinez-MedinaI, CamposA, et al.Tissue engineering strategies for the treatment of tendon injuries: A systematic review and meta-analysis of animal models. Bone Joint Res, 2018; 7(4):318–324; doi: 10.1302/2046-3758.74.BJR-2017-0326
27.
ShethVH, ShahNP, JainR, et al.Development and validation of a risk-of-bias tool for assessing in vitro studies conducted in dentistry: The QUIN. J Prosthet Dent, 2024; 131(6):1038–1042; doi: 10.1016/j.prosdent.2022.05.019
28.
AlaminosM, GarzonI, Sanchez-QuevedoMC, et al.Time-course study of histological and genetic patterns of differentiation in human engineered oral mucosa. J Tissue Eng Regen Med, 2007; 1(5):350–359; doi: 10.1002/term.38
29.
BayarGR, KuoS, MarceloCL, et al.In vitro development of a mucocutaneous junction for lip reconstruction. J Oral Maxillofac Surg, 2016; 74(11):2317–2326; doi: 10.1016/j.joms.2016.04.002
30.
GarzonI, SerratoD, RodaO, et al.In vitro cytokeratin expression profiling of human oral mucosa substitutes developed by tissue engineering. Int J Artif Organs, 2009; 32(10):711–719; doi: 10.1177/039139880903201002
31.
GolinskiPA, GrogerS, HerrmannJM, et al.Oral mucosa model based on a collagen-elastin matrix. J Periodontal Res, 2011; 46(6):704–711; doi: 10.1111/j.1600-0765.2011.01393.x
32.
JenningsLR, ColleyHE, OngJ, et al.Development and characterization of in vitro human oral mucosal equivalents derived from immortalized oral keratinocytes. Tissue Eng Part C Methods, 2016; 22(12):1108–1117; doi: 10.1089/ten.TEC.2016.0310
33.
KhmaladzeA, GangulyA, KuoS, et al.Tissue-engineered constructs of human oral mucosa examined by Raman spectroscopy. Tissue Eng Part C Methods, 2013; 19(4):299–306; doi: 10.1089/ten.TEC.2012.0287
34.
KinikogluB, AuxenfansC, PierrillasP, et al.Reconstruction of a full-thickness collagen-based human oral mucosal equivalent. Biomaterials, 2009; 30(32):6418–6425; doi: 10.1016/j.biomaterials.2009.08.010
35.
KinikogluB, HemarJ, HasirciV, et al.Feasibility of a porcine oral mucosa equivalent: A preclinical study. Artif Cells Blood Substit Immobil Biotechnol, 2012; 40(4):271–274; doi: 10.3109/10731199.2011.644293
36.
KriegebaumU, MildenbergerM, Mueller-RichterUD, et al.Tissue engineering of human oral mucosa on different scaffolds: In vitro experiments as a basis for clinical applications. Oral Surg Oral Med Oral Pathol Oral Radiol, 2012; 114(5 Suppl):S190–S8; doi: 10.1016/j.oooo.2011.10.019
37.
LoWL, LaiJY, FeinbergSE, et al.Raman spectroscopy monitoring of the cellular activities of a tissue-engineered produced oral mucosal equivalent. J Raman Spectroscopy, 2011; 42(2):174–178; doi: 10.1002/jrs.2688
38.
LuitaudC, LaflammeC, SemlaliA, et al.Development of an engineering autologous palatal mucosa-like tissue for potential clinical applications. J Biomed Mater Res B Appl Biomater, 2007; 83(2):554–561; doi: 10.1002/jbm.b.30828
39.
NakanishiY, IzumiK, YoshizawaM, et al.The expression and production of vascular endothelial growth factor in oral mucosa equivalents. Int J Oral Maxillofac Surg, 2007; 36(10):928–933; doi: 10.1016/j.ijom.2007.06.013
40.
NavarroFA, MizunoS, HuertasJC, et al.Perfusion of medium improves growth of human oral neomucosal tissue constructs. Wound Repair Regen, 2001; 9(6):507–512; doi: 10.1046/j.1524-475x.2001.00507.x
41.
NishiyamaK, AkagiT, IwaiS, et al.Construction of vascularized oral mucosa equivalents using a layer-by-layer cell coating technology. Tissue Eng Part C Methods, 2019; 25(5):262–275; doi: 10.1089/ten.TEC.2018.0337
42.
PenaI, JunqueraLM, MeanaA, et al.In vitro engineering of complete autologous oral mucosa equivalents: Characterization of a novel scaffold. J Periodontal Res, 2010; 45(3):375–380; doi: 10.1111/j.1600-0765.2009.01248.x
43.
Perez-AmodioS, TraWM, RakhorstHA, et al.Hypoxia preconditioning of tissue-engineered mucosa enhances its angiogenic capacity in vitro. Tissue Eng Part A, 2011; 17(11–12):1583–1593; doi: 10.1089/ten.TEA.2010.0429
44.
PetersK, WiesmannN, HeimesD, et al.Extracorporeal shock wave therapy improves in vitro formation of multilayered epithelium of oral mucosa equivalents. Biomedicines, 2022; 10(3):700; doi: 10.3390/biomedicines10030700
45.
TabatabaeiF, MoharamzadehK, TayebiL. Fibroblast encapsulation in Gelatin Methacryloyl (GelMA) versus collagen hydrogel as substrates for oral mucosa tissue engineering. J Oral Biol Craniofac Res, 2020; 10(4):573–577; doi: 10.1016/j.jobcr.2020.08.015
46.
TeradaM, IzumiK, OhnukiH, et al.Construction and characterization of a tissue-engineered oral mucosa equivalent based on a chitosan-fish scale collagen composite. J Biomed Mater Res B Appl Biomater, 2012; 100(7):1792–1802; doi: 10.1002/jbm.b.32746
47.
TraWM, van NeckJW, HoviusSE, et al.Characterization of a three-dimensional mucosal equivalent: Similarities and differences with native oral mucosa. Cells Tissues Organs, 2012; 195(3):185–196; doi: 10.1159/000324918
48.
TraWM, SpiegelbergL, TukB, et al.Hyperbaric oxygen treatment of tissue-engineered mucosa enhances secretion of angiogenic factors in vitro. Tissue Eng Part A, 2014; 20(9–10):1523–1530; doi: 10.1089/ten.TEA.2012.0629
49.
Vinuela-PrietoJM, Sanchez-QuevedoMC, Alfonso-RodriguezCA, et al.Sequential keratinocytic differentiation and maturation in a three-dimensional model of human artificial oral mucosa. J of Periodontal Research, 2015; 50(5):658–665; doi: 10.1111/jre.12247
50.
WinterrothF, LeeJ, KuoS, et al.Acoustic microscopy analyses to determine good vs. failed tissue engineered oral mucosa under normal or thermally stressed culture conditions. Ann Biomed Eng, 2011; 39(1):44–52; doi: 10.1007/s10439-010-0176-2
51.
WinterrothF, KatoH, KuoS, et al.High-frequency ultrasonic imaging of growth and development in manufactured engineered oral mucosal tissue surfaces. Ultrasound Med Biol, 2014; 40(9):2244–2251; doi: 10.1016/j.ultrasmedbio.2014.03.007
52.
XiongX, ZhaoY, ZhangW, et al.In vitro engineering of a palatal mucosa equivalent with acellular porcine dermal matrix. J Biomed Mater Res A, 2008; 86(2):544–551; doi: 10.1002/jbm.a.31689
53.
XiongX, JiaJ, HeS, et al.Cryopreserved lip mucosa tissue derived keratinocytes can fabricate tissue engineered palatal mucosa equivalent. J Biomed Mater Res B Appl Biomater, 2010; 94(1):165–170; doi: 10.1002/jbm.b.31637
54.
AhnKM, LeeJH, HwangSJ, et al.Fabrication of myomucosal flap using tissue-engineered bioartificial mucosa constructed with oral keratinocytes cultured on amniotic membrane. Artif Organs, 2006; 30(6):411–423; doi: 10.1111/j.1525-1594.2006.00236.x
55.
Alfonso-RodriguezCA, Gonzalez-AndradesE, Jaimes-ParraBD, et al.Ex vivo and in vivo modulatory effects of umbilical cord Wharton’s jelly stem cells on human oral mucosa stroma substitutes. Histol Histopathol, 2015; 30(11):1321–1332.
56.
ButlerCE, NavarroFA, ParkCS, et al.Regeneration of neomucosa using cell-seeded collagen-GAG matrices in athymic mice. Ann Plast Surg, 2002; 48(3):298–304; doi: 10.1097/00000637-200203000-00012
57.
GarzonI, Sanchez-QuevedoMC, MoreuG, et al.In vitro and in vivo cytokeratin patterns of expression in bioengineered human periodontal mucosa. J Periodontal Res, 2009; 44(5):588–597; doi: 10.1111/j.1600-0765.2008.01159.x
58.
GarzonI, MiyakeJ, Gonzalez-AndradesM, et al.Wharton’s jelly stem cells: A novel cell source for oral mucosa and skin epithelia regeneration. Stem Cells Transl Med, 2013; 2(8):625–632; doi: 10.5966/sctm.2012-0157
59.
GonzalezL, PadronK, SalmenS, et al.Oral mucosa analog allografts in non-consanguineous rats. Biomedica, 2017; 37(1):111–118; doi: 10.7705/biomedica.v37i2.3006
60.
KhmaladzeA, KuoS, KimRY, et al.Human oral mucosa tissue-engineered constructs monitored by Raman fiber-optic probe. Tissue Eng Part C Methods, 2015; 21(1):46–51; doi: 10.1089/ten.TEC.2013.0622
61.
KuoS, ZhouY, KimHM, et al.Biochemical indicators of implantation success of tissue-engineered oral mucosa. J Dent Res, 2015; 94(1):78–84; doi: 10.1177/0022034514554225
62.
LloydWR, LeeSY, ElahiSF, et al.Noninvasive optical assessment of implanted tissue-engineered construct success in situ. Tissue Eng Part C Methods, 2021; 27(5):287–295; doi: 10.1089/ten.TEC.2021.0018
63.
PenaI, JunqueraLM, MeanaA, et al.In vivo behavior of complete human oral mucosa equivalents: Characterization in athymic mice. J Periodontal Res, 2011; 46(2):214–220; doi: 10.1111/j.1600-0765.2010.01330.x
64.
RouabhiaM, AllaireP. Gingival mucosa regeneration in athymic mice using in vitro engineered human oral mucosa. Biomaterials, 2010; 31(22):5798–5804; doi: 10.1016/j.biomaterials.2010.04.004
65.
StrassburgS, CaducM, StarkGB, et al.In vivo evaluation of an electrospun gelatin nonwoven mat for regeneration of epithelial tissues. J Biomed Mater Res A, 2019; 107(8):1605–1614; doi: 10.1002/jbm.a.36676
66.
YoshizawaM, KoyamaT, KojimaT, et al.Keratinocytes of tissue-engineered human oral mucosa promote re-epithelialization after intraoral grafting in athymic mice. J Oral Maxillofac Surg, 2012; 70(5):1199–1214; doi: 10.1016/j.joms.2011.03.057
67.
ZhouM, ChenX, QiuY, et al.Study of tissue engineered vascularised oral mucosa-like structures based on ACVM-0.25% HLC-I scaffold in vitro and in vivo. Artif Cells Nanomed Biotechnol, 2020; 48(1):1167–1177; doi: 10.1080/21691401.2020.1817055
68.
IzumiK, FeinbergSE, TerashiH, et al.Evaluation of transplanted tissue-engineered oral mucosa equivalents in severe combined immunodeficient mice. Tissue Eng, 2003; 9(1):163–174; doi: 10.1089/107632703762687645
69.
IidaT, TakamiY, YamaguchiR, et al.Development of a tissue-engineered human oral mucosa equivalent based on an acellular allogeneic dermal matrix: A preliminary report of clinical application to burn wounds. Scand J Plast Reconstr Surg Hand Surg, 2005; 39(3):138–146; doi: 10.1080/0284431051006376
70.
IzumiK, FeinbergSE, IidaA, et al.Intraoral grafting of an ex vivo produced oral mucosa equivalent: A preliminary report. Int J Oral Maxillofac Surg, 2003; 32(2):188–197; doi: 10.1054/ijom.2002.0365
71.
IzumiK, NeivaRF, FeinbergSE. Intraoral grafting of tissue-engineered human oral mucosa. Int J Oral Maxillofac Implants, 2013; 28(5):e295-303–e303; doi: 10.11607/jomi.te11
72.
Delgado-RodriguezM. Systematic reviews of meta-analyses: Applications and limitations. J Epidemiol Community Health, 2006; 60(2):90–92; doi: 10.1136/jech.2005.035253
73.
HuangW, Percie Du SertN, VollertJ, et al.General principles of preclinical study design. Handb Exp Pharmacol, 2020; 257:55–69; doi: 10.1007/164_2019_277
74.
SmiraniR, RemyM, DevillardR, et al.Engineered prevascularization for oral tissue grafting: A systematic review. Tissue Eng Part B Rev, 2020; 26(4):383–398; doi: 10.1089/ten.TEB.2020.0093
MooreEM, WestJL. Harnessing macrophages for vascularization in tissue engineering. Ann Biomed Eng, 2019; 47(2):354–365; doi: 10.1007/s10439-018-02170-4
77.
VasanthanJ, GurusamyN, RajasinghS, et al.Role of human mesenchymal stem cells in regenerative therapy. Cells, 2020; 10(1):54; doi: 10.3390/cells10010054
78.
KinikogluB, RovereMR, HaftekM, et al.Influence of the mesenchymal cell source on oral epithelial development. J Tissue Eng Regen Med, 2012; 6(3):245–252; doi: 10.1002/term.426
79.
LiuJ, MaoJJ, ChenL. Epithelial-mesenchymal interactions as a working concept for oral mucosa regeneration. Tissue Eng Part B Rev, 2011; 17(1):25–31; doi: 10.1089/ten.TEB.2010.0489
80.
GelinA, Masson-MeyersD, AminiF, et al.Collagen: The superior material for full-thickness oral mucosa tissue engineering. J Oral Biosci, 2024; 66(3):511–518; doi: 10.1016/j.job.2024.06.006
81.
JansenLA, De CaignyP, GuayNA, et al.The evidence base for the acellular dermal matrix AlloDerm: A systematic review. Ann Plast Surg, 2013; 70(5):587–594; doi: 10.1097/SAP.0b013e31827a2d23
82.
Sanz-HortaR, MatesanzA, GallardoA, et al.Technological advances in fibrin for tissue engineering. J Tissue Eng, 2023; 14:20417314231190288; doi: 10.1177/20417314231190288
83.
ParkCH, WooKM. Fibrin-Based biomaterial applications in tissue engineering and regenerative medicine. Adv Exp Med Biol, 2018; 1064:253–261; doi: 10.1007/978-981-13-0445-3_16
84.
LauritanoD, LimongelliL, MoreoG, et al.Nanomaterials for periodontal tissue engineering: Chitosan-Based scaffolds. A systematic review. Nanomaterials (Basel), 2020; 10(4):605; doi: 10.3390/nano10040605
85.
BarrientosS, StojadinovicO, GolinkoMS, et al.Growth factors and cytokines in wound healing. Wound Repair Regen, 2008; 16(5):585–601; doi: 10.1111/j.1524-475X.2008.00410.x
86.
WardE. A review of tissue engineering for periodontal tissue regeneration. J Vet Dent, 2022; 39(1):49–62; doi: 10.1177/08987564211065137
87.
Atienza-RocaP, CuiX, HooperGJ, et al.Growth factor delivery systems for tissue engineering and regenerative medicine. Adv Exp Med Biol, 2018; 1078:245–269; doi: 10.1007/978-981-13-0950-2_13
88.
OngHT, DilleyRJ. Novel non-angiogenic role for mesenchymal stem cell-derived vascular endothelial growth factor on keratinocytes during wound healing. Cytokine Growth Factor Rev, 2018; 44:69–79; doi: 10.1016/j.cytogfr.2018.11.002
89.
Blanco-ElicesC, Morales-AlvarezC, Chato-AstrainJ, et al.Development of stromal differentiation patterns in heterotypical models of artificial corneas generated by tissue engineering. Front Bioeng Biotechnol, 2023; 11:1124995; doi: 10.3389/fbioe.2023.1124995
90.
ZhangJ, WehrleE, RubertM, et al.3D bioprinting of human tissues: Biofabrication, bioinks, and bioreactors. Int J Mol Sci, 2021; 22(8):3971; doi: 10.3390/ijms22083971
91.
GuoH, XuX, ZhangJ, et al.The pivotal role of preclinical animal models in anti-cancer drug discovery and personalized cancer therapy strategies. Pharmaceuticals (Basel), 2024; 17(8):1048; doi: 10.3390/ph17081048
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
